187 related articles for article (PubMed ID: 16169225)
1. Letrozole for brain and scalp metastases from breast cancer--a case report.
Madhup R; Kirti S; Bhatt ML; Srivastava PK; Srivastava M; Kumar S
Breast; 2006 Jun; 15(3):440-2. PubMed ID: 16169225
[TBL] [Abstract][Full Text] [Related]
2. [A case of scalp metastases from breast cancer successfully treated with letrozole].
Kuwayama T; Sato T; Nakagawa T; Sugimoto H; Ishiba T; Kubota K; Sugihara K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2183-5. PubMed ID: 22202323
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of letrozole in the breast cancer treatment continuum.
Monnier A
Breast; 2006 Feb; 15 Suppl 1():S1-2. PubMed ID: 16500234
[No Abstract] [Full Text] [Related]
4. Remission of metastatic primary mucinous carcinoma of the skin with anastrozole.
Shockman S; Krug L; Lountzis N
J Am Acad Dermatol; 2014 Jul; 71(1):e27-8. PubMed ID: 24947711
[No Abstract] [Full Text] [Related]
5. The evolving role of letrozole in the adjuvant setting: first results from the large, phase III, randomized trial BIG 1-98.
Monnier A
Breast; 2006 Feb; 15 Suppl 1():S21-9. PubMed ID: 16500237
[TBL] [Abstract][Full Text] [Related]
6. Review of the development of letrozole and its use in advanced breast cancer and in the neoadjuvant setting.
Bhatnagar AS
Breast; 2006 Feb; 15 Suppl 1():S3-13. PubMed ID: 16500235
[TBL] [Abstract][Full Text] [Related]
7. A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
Ito K; Ito T; Okada T; Watanabe T; Gomi K; Kanai T; Mochizuki Y; Amano J
Breast J; 2009; 15(4):435-7. PubMed ID: 19470131
[No Abstract] [Full Text] [Related]
8. Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.
Rasmussen BB; Regan MM; Lykkesfeldt AE; Dell'Orto P; Del Curto B; Henriksen KL; Mastropasqua MG; Price KN; Méry E; Lacroix-Triki M; Braye S; Altermatt HJ; Gelber RD; Castiglione-Gertsch M; Goldhirsch A; Gusterson BA; Thürlimann B; Coates AS; Viale G;
Lancet Oncol; 2008 Jan; 9(1):23-8. PubMed ID: 18083065
[TBL] [Abstract][Full Text] [Related]
9. Prescribing extended adjuvant letrozole.
Gelmon K
Breast; 2007 Oct; 16(5):446-55. PubMed ID: 17544670
[TBL] [Abstract][Full Text] [Related]
10. The use of early adjuvant aromatase inhibitor therapy: contributions from the BIG 1-98 letrozole trial.
Forbes JF
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S2-7. PubMed ID: 16730270
[TBL] [Abstract][Full Text] [Related]
11. An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.
Barnadas A; Estévez LG; Lluch-Hernández A; Rodriguez-Lescure A; Rodriguez-Sanchez C; Sanchez-Rovira P
Adv Ther; 2011 Dec; 28(12):1045-58. PubMed ID: 22068628
[TBL] [Abstract][Full Text] [Related]
12. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
Kaufmann M; Rody A
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):146-54. PubMed ID: 16621229
[TBL] [Abstract][Full Text] [Related]
13. The extended adjuvant NCIC CTG MA.17 trials: initial and rerandomization studies.
Pritchard KI; Goss PE; Shepherd L
Breast; 2006 Feb; 15 Suppl 1():S14-20. PubMed ID: 16500236
[TBL] [Abstract][Full Text] [Related]
14. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
Monnier AM
Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
[TBL] [Abstract][Full Text] [Related]
15. Intermittent letrozole therapy for metastatic breast cancer: case reports and literature review.
Fan L; Liedke PE; Isakoff SJ; St Louis J; Ryan PD; Goss PE
Clin Breast Cancer; 2014 Apr; 14(2):e41-5. PubMed ID: 24342729
[No Abstract] [Full Text] [Related]
16. Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients.
Bottini A; Generali D; Brizzi MP; Fox SB; Bersiga A; Bonardi S; Allevi G; Aguggini S; Bodini G; Milani M; Dionisio R; Bernardi C; Montruccoli A; Bruzzi P; Harris AL; Dogliotti L; Berruti A
J Clin Oncol; 2006 Aug; 24(22):3623-8. PubMed ID: 16877730
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibitors in the treatment of early and advanced breast cancer.
Joensuu H; Ejlertsen B; Lønning PE; Rutqvist LE
Acta Oncol; 2005; 44(1):23-31. PubMed ID: 15848903
[TBL] [Abstract][Full Text] [Related]
18. Letrozole in advanced breast cancer: the PO25 trial.
Mouridsen HT
Breast Cancer Res Treat; 2007; 105 Suppl 1(Suppl 1):19-29. PubMed ID: 17333340
[TBL] [Abstract][Full Text] [Related]
19. Management of choroidal metastases from breast carcinomas using aromatase inhibitors.
Manquez ME; Brown MM; Shields CL; Shields JA
Curr Opin Ophthalmol; 2006 Jun; 17(3):251-6. PubMed ID: 16794437
[TBL] [Abstract][Full Text] [Related]
20. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
